Paul Berns

Investor

Managing Director at ARCH Venture Partners

Wisconsin

Writes $50K – $150M checks · typically $25M

FoundedAreteia Therapeutics Mirador Therapeutics Neumora Therapeutics

About

Paul Berns is a pharma operator who helped architect Humira, led Anacor (sold to Pfizer for over $5 billion), co-founded and runs Neumora, with unusually direct large-scale commercialization experience.

Invests in

AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices

Deals · 1

Ollin Biosciences, Inc.Board seat

via ARCH Venture Partners · filed Jun 2026 · $330M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at ARCH Venture Partners

Ari Nowacek

Partner at ARCH Venture Partners

Axel Bouchon

Venture Partner at ARCH Venture Partners

Brian Cuneo

Senior Partner at ARCH Venture Partners

Carol Suh

Partner at ARCH Venture Partners

Clinton Bybee

Co-founder & Managing Director, Emeritus at ARCH Venture Partners

Corey Ritter

Partner at ARCH Venture Partners

David Moore

Senior Partner at ARCH Venture Partners

George Scangos

Venture Partner at ARCH Venture Partners

Network1

Amir Nashat

Entrepreneur Partner at Polaris Partners

Investors connected to Paul in public investor directories — a warm-intro map.